US-Vorbörse: IBM, Eaton Vance, Regeneron, Eli Lilly und Tesla mit ... - dofaq.co
US-Vorbörse: IBM, Eaton Vance, Regeneron, Eli Lilly und Tesla mit ...
AKTIONÄR-Top-Tipp Regeneron: Bockstarke Zahlen – magische Marke geknackt
Regeneron: Wichtiger Erfolg – Aktie auf Rekordjagd - DER AKTIONÄR
VIRICA Index gibt Vollgas: Regeneron, Amgen und Vertex auf Rekordhoch
Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth
Regeneron, Mammoth Launch In Vivo CRISPR Gene Editing Collaboration
Sales of Roche's juggernaut Vabysmo rout the analyst consensus
AbbVie's Rinvoq shows superiority to Regeneron's Dupixent in study
Regeneron signs Mammoth gene editing deal worth $100M upfront
Regeneron and Mammoth announce gene editing partnership worth $370m per target
Regeneron and Mammoth Biosciences to Collaborate
Regeneron and Mammoth team up to develop gene editing therapies
Regeneron Pharmaceuticals Inc. stock underperforms Friday when compared to competitors
Regeneron Bets $100M That Mammoth’s CRISPR Tech Can Deliver on Next Wave of Genetic Medicines
Regeneron inks $100M deal to develop gene-editing therapies
Regeneron Pays Mammoth $100M to Access CRISPR Enzymes for AAV Delivery
AKTIONÄR-Top-Tipp Regeneron schlägt zu: Übernahme – Aktie schießt über 80 Prozent hoch
Head-to-head, it's AbbVie's Rinvoq over Regeneron's Dupixent
AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study
Regeneron to defend against DOJ complaint on drug-price manipulation
